<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> are an important cause of morbidity and mortality and are the leading cause of <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) proved to be effective in reducing both <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality, the ideal therapy remains to be defined because <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> implantation allows to interrupt life-threatening <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> but does not prevent them </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions, in terms of shock delivery and antitachycardia pacing, are often associated with invalidating symptoms, such as <z:hpo ids='HP_0100749'>chest pain</z:hpo>, sensation of <z:hpo ids='HP_0001649'>rapid heartbeat</z:hpo> and <z:hpo ids='HP_0001279'>syncope</z:hpo>, and may cause <z:hpo ids='HP_0000716'>depression</z:hpo> in many patients </plain></SENT>
<SENT sid="3" pm="."><plain>Both appropriate and inappropriate shocks have been shown to be associated with a worse prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>Transcatheter ablation proved to be safe and effective in reducing <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> relapse in patients who experience multiple <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> interventions or electrical storm </plain></SENT>
<SENT sid="5" pm="."><plain>In the latter patient subset, ablation often represents the only possibility of interrupting such dramatic events </plain></SENT>
<SENT sid="6" pm="."><plain>Ablation has also been evaluated in patients implanted with an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> in secondary prevention, before device intervention </plain></SENT>
<SENT sid="7" pm="."><plain>To date, transcatheter ablation represents an optimal opportunity, complementary to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>, in the treatment of patients at high risk for <z:hpo ids='HP_0001699'>sudden death</z:hpo> and episodes of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
</text></document>